Autologous cytokine-induced killer cell therapy

自体细胞因子诱导的杀伤细胞疗法

Report date: 2024/11/26 20:00:06

Base Information

Drug NameAutologous cytokine-induced killer cell therapy

Drug Alias NameAutologous cytokine-induced killer cells

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cellCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder NeoplasmsKidney Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

Active IndicationsN/A

Inactive IndicationsUrinary Bladder NeoplasmsKidney Neoplasms

Other Information

ATC CodeN/A